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Background: Access to prescription contraception is often limited by the availability of physicians, particularly in rural areas. Pharmacists are
available but are not authorized in Canada to prescribe contraceptives, an innovation proved successful in the United States. It is unknownwhether
Canadian pharmacists, particularly those in rural areas, are willing to adopt this innovation and what barriers and facilitators they predict. We
explored the acceptability and feasibility for independent provision of contraception at pharmacies throughout British Columbia (BC).
Methods: This mixed-methods study used validated questionnaires followed by optional structured interviews among all rural, and a sample
of urban, community pharmacies in BC. Analyses use descriptive, logistic regression and qualitative thematic evaluation.
Results: Responding community pharmacies represent all geographic health regions of BC and the range of pharmacy business models.
Respondents reported a mean of 17 years in practice. Seventy percent of pharmacies reported a private counseling area. Over 80%, including
pharmacies in all regions, indicated willingness to prescribe hormonal contraceptives. Factors associated with willingness to prescribe were
comfort using a protocol to assess sexual history, confidence about staff availability and public acceptability, and fewer years in practice.
Pharmacists requested training in assessment protocols and liability issues prior to implementation.
Interpretation: Pharmacies from all areas throughout BC, responded and report a high degree of acceptability and feasibility for independent
prescription of hormonal contraceptives. As pharmacists are often the most accessible health professional in rural areas, pharmacist provision
of hormonal contraceptives has potential to improve access to contraception.
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Access to prescription contraceptives is an important
Canadian problem. One in three women have at least one
abortion prior to reaching menopause [1], and Black et al.
found that one in six women currently at risk for an
unwanted pregnancy did not use any method of contracep-
tion at last intercourse [2]. Inability to arrange and attend an
appointment with a professional able to prescribe contra-
ception, and then to attend a pharmacy to dispense the
contraception, contributes to unintended pregnancy [3]. In
Canada, hormonal contraceptives are available through
prescription from physicians, nurse-practitioners andess article under the CC BY-NC-ND license (http://creativecommons.org/
56 W.V. Norman et al. / Contraception 92 (2015) 55–61midwives, but not directly from pharmacists. Geographic
distributions of prescribing professions are concentrated in
large urban settings, disproportionate to the distribution of
women throughout Canada [4]. In rural areas of Canada,
women face limited hours and in many cases significant travel
to access a health professional able to prescribe contraception.
Potential barriers to pharmacist prescription of contra-
ception, such as proper patient screening, are surmountable.
Pharmacists are trusted health professionals [5] with highly
accessible hours and locations. Current Canadian regulations
are increasingly expanding pharmacist scope of practice,
including independent prescription of a variety of medica-
tions [6–8]. Models exist in the United States to allow
pharmacists to independently initiate prescription contracep-
tion [9]. For example, Gardiner’s Direct Access study
demonstrated effectiveness and acceptability for pharmacists
to independently provide hormonal contraceptives using
protocols [10]. In British Columbia (BC), registered nurses
may acquire certification in contraception management,
allowing them to use decision-making tools to independently
dispense or administer hormonal contraception [11–13].
These decision-making tools use history and the measure-
ment of blood pressure to screen women for suitability for
hormonal contraception [14–16]. Pharmacists in Canada
have attained certifications to utilize a broad range of
decision-making tools for independent provision of pre-
scriptions, such as emergency contraceptive pills, immuni-
zations and management for asthma, anticoagulants and
other conditions [17,6,18]. Evidence has demonstrated that
automated office measurement of blood pressure, such as by
pharmacists, is accurate, reliable and preferable to physician
office manual blood pressure measurement [19]. No
evidence currently exists on the willingness among Canadian
pharmacists to adopt an innovative practice to independently
provide hormonal contraception.
We developed the “Acceptability of Contraception
Task-sharing for Pharmacists” (ACT-Pharm) study to
answer the question: “Is the independent prescription of
hormonal contraception acceptable and feasible at commu-
nity pharmacies distributed throughout BC?” We hypothe-
sized that every rural area will have pharmacies willing to
adopt this innovation. Further, we sought to understand
potential facilitators and barriers to implementation of this
innovation, as identified by community pharmacies.2. Methods
For this mixed-methods study, we distributed a validated
multiple-choice questionnaire [19] to community pharma-
cies and invited participants to volunteer for a semistructured
qualitative interview with open-ended questions. The
questionnaire and the interview script both addressed all
conceptual constructs for successful integration of an
innovation into practice, as framed within Roger’s theory
of Diffusion of Innovations [21,22]. We have described thedevelopment, review, iterative pilot testing and validation of
the survey [20]. Ethics approval was obtained from the
University of BC, Children’s and Women’s Research Ethics
Board (H12-01569).
We obtained a list of all licensed community pharmacies
from the BC College of Pharmacists [23]. Urban pharmacies
were defined as those within a Census Metropolitan Area
(CMA) according to Statistics Canada [24,25]. Rural
pharmacies were defined as not located in a CMA and not
sampled during our pilot phase testing (n=333). Our
intention was to understand the potential to increase access
to hormonal contraception where hours of physician services
are limited. As such, we included all rural pharmacies, and
for comparison purposes, a small sample of pharmacies was
chosen from urban areas. We grouped a postal-code-ordered
list of all urban pharmacies into numbered clusters of six and
then, using an online randomization number generator,
selected seven random clusters (n=42) of urban pharmacies.
2.1. Survey distribution
We distributed self-completion questionnaires (Appendix
A. ACT-Pharm Questionnaire) on October 18, 2012, with a
choice of paper or electronic versions (compliant with the
BC Freedom of Information and Protection of Privacy Act
[26]). The survey was open until December 11, 2012. We
used Dillman’s “Tailored Design” methods for survey
distribution and follow-up [27], including faxed reminder
notices to nonresponders at 1, 3 and 5 weeks from the initial
invitation and a 2-week visit or telephone reminder by
pharmacy student volunteers. Respondents who volunteered
to participate in an interview were contacted to arrange a
time at their convenience. All interviews were semistruc-
tured, asking open-ended questions with key prompts to
expand upon the answers (see Appendix B. ACT-Pharm
Interview Script). Interviews were recorded and then
transcribed by a professional transcriptionist.
2.2. Analysis
All quantitative analyses were performed in R version
2.15.3 [28]. Descriptive statistics (proportion, mean and
standard deviation) were used to characterize responder
demographics. Bivariate analyses (χ2 tests) and logistic
regressions were used to find correlates of willingness to
prescribe contraception, and to determine correlates of
barriers and facilitators to this innovative practice.
We compared the two key survey questions (willingness
to adopt innovations and willingness to prescribe hormonal
contraception) between the two groups using χ2 tests of
independence. This allowed determination of whether
responses of urban and rural pharmacy respondents could
be combined for the analyses. We tested internal reliability
using a repeated rephrased question on willingness to adopt
innovations to obtain a Cohen’s Kappa value.
We performed logistic regression to determine factors
related to willingness to prescribe hormonal contraception,
able 1
haracteristics of responding pharmacies in BC, n=145
haracteristic n (%)
ll responders (% among 374 sampled) 145 (38.8)
Rural (% among 332 in rural sample) 128 (38.6)
Urban (% among 42 in urban sample) 15 (35.7)
Unknown rural/urban status 2
egion (% among sample for region)
Vancouver Coastal 15 (31.7)
Vancouver Island 38 (48.2)
Interior 42 (38.7)
Fraser 14 (48.1)
Northern 24 (49.5)
Unknown region 10
harmacy type
Banner/chain/franchise pharmacy 93 (64.1)
Pharmacy department within a mass-merchandise store 23 (15.9)
Independent pharmacy 11 (7.6)
Unknown pharmacy type 18 (12.4)
verage FTE pharmacists at this pharmacy (SD) 1.9 (0.9)
esponding pharmacist
Male 69 (47.6)
Female 58 (40.0)
Not specified 18 (12.4)
osition of respondent
Owner or manager/FT pharmacist 84 (57.9)
Full time (not owner or manager) 27 (18.6)
Part time or floater 15 (10.3)
ean number of years since graduation of respondent (SD) 16.8 (11.1)
nhanced certifications of respondent
Any (e.g., First Aid, CPR, immunizations) 109 (75.2)
Mean number of certifications (SD) 2.2 (1.3)
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legislative authority today I would be interested in
prescribing hormonal contraceptives’ and ‘If a pilot project
to prescribe hormonal contraceptives was available I would
be interested in participating’ — using multivariable
regression against a list of 12 variables on pharmacist
training, attitudes regarding barriers and comfort levels, as
well as compared to self-described willingness to adopt
innovations. We then simplified the model using stepwise
regression using the Akaike Information Criterion (AIC) as
implemented in the ‘stepAIC’ function in the MASS package
[29] to calculate adjusted odds ratios.
The qualitative inductive thematic analysis was assisted
by use of the program NVivo 10 [30]. D.P. read the first four
interviews and identified four broad, descriptive categories
reflecting the semistructured interview themes: barriers or
challenges, benefits or advantages, capacity and pharma-
cists’ opinions. A coding scheme of 20 first-level codes was
developed under these larger themes and applied to the
original four transcripts. The scheme was tested on an
additional four transcripts. The themes, codes and findings
were discussed with W.N. before coding the remaining
transcripts. A second meeting was held between D.P., W.N.
and J.S. until agreement on all categories was achieved. The
20 first-level categories collapsed to 16 and 5 second-level
codes were added to further define key concepts. All
transcripts were then recoded using the final scheme.
Thematic quotes aligned closely with survey findings.
Typical examples are presented in context with the related
quantitative results.3. Results
Respondents represented all geographic health regions of
BC (Table 1). Questionnaires were returned from 146/375
invited pharmacies, including one respondent incorrectly
invited (not a community pharmacy). Response rates among
rural and urban pharmacies were similar. Half of respondents
volunteered for interviews. A regionally representative
sample (17 rural, 2 urban) was interviewed.
The χ2 tests compared urban and rural respondents for
the proportion of those self-described as a willing adopter of
innovation and with a willingness to prescribe hormonal
contraception, yielding p values=0.91 and .07, respectively,
suggesting that there is no substantial difference between
urban and rural respondents. They were combined for further
analysis. Internal reliability yielded fairly consistent results
with a Cohen’s Kappa=0.61, pb.0001.
3.1. Characteristics of pharmacies
Responding pharmacies represented the range of business
models and predominantly were locations with two or fewer
pharmacists on duty each day, reflecting the purposive
rurality of the sample. The respondent pharmacist was most
often the owner or manager and reported a mean 17 (SD 11)T
C
C
A
R
P
A
R
P
M
Eyears of experience in community pharmacy. Most were
certified in immunizations and first aid, and more than half in
cardiopulmonary resuscitation. Participants’ self-character-
ization for willingness to adopt innovations and new
pharmacy practices in general divided fairly evenly between
those willing (Innovation-adopters) and those less willing
(Conservative-adopters), with three missing responses.
3.2. Willingness to independently prescribe
hormonal contraception
Respondents’ perception of the advantage of the innova-
tion was collected through questions on the perceived
advantages for patients, pharmacists and society (Appendix
C: Detailed Results 1). Eighty-seven percent of pharmacies
felt that this innovation would confer increased access for
women and couples to contraception and that it could reduce
pressure on the health care system through the prevention of
unintended pregnancies. Eighty percent agreed that this
would increase collaboration between pharmacists and other
health professionals. Most agreed that it would increase job
satisfaction for pharmacists. “[This]…also provides the
pharmacist with more autonomy. It gives them more—I
think on the pharmacist side, gives them more pride in what
they’re doing,…as long as there’s appropriate training, a
course. I think pharmacists are more than capable.”
Table 2
Logistic regression results for willingness to prescribe
Associated factor Willingness to prescribe, OR (95% CI) Significance
Comfort taking a sexual history assessment using a protocola 13.3 (3.7–58.7) pb.001
Self-defined Innovation adopter 10.0 (2.5–50) pb.01
No concern over lack of staff 7.1 (1.6–33.3) pb.05
No concern there may be resistance from the public 5.6 (1.2–33.3) pb.05
Years in practice as a community pharmacist 0.92 (0.86–0.98) pb.05
Shown are odds ratios (95% confidence interval) and p values from likelihood ratio tests.
a Likert scale from 1 to 5.
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private counseling facilities. Most (60%) report the presence
of a private room for counseling, particularly pharmacies in
rural areas, and many others report the presence of a private
counseling area within the dispensary. Interviews indicated
that pharmacists found the proposed innovation to be
compatible with their current practice: “I mean, the way it
is right now, I’m often asked by doctors to help a patient
decide. Like, say they’re having a problem with their
contraceptive that they’re on, they’ll ask me to help work out
which one would be the best in that situation.”
Overall, pharmacists indicated a high degree of comfort
with the complex tasks required for this innovation, with
roughly 90% agreeing that they have the skills for
assessment, examination, decision making and follow-up.
Two thirds indicated that they would be comfortable using a
protocol to ask risk assessment questions about the patient’s
sexual history. “Oh, yes, yeah, I’m comfortable because I
can do counselling and I can explain to the customers too,
right, how to use and all this. So yeah, I am comfortable to
do this for sure.”
Respondents did not agree that either cost considerations
for start-up of this innovation or resistance from the public
would be a barrier to implementation, although 80% were
concerned that lack of compensation for this new cognitive
task could be a barrier, and about half had concerns over
potential liability. “Yeah,…so I think that the remuneration
needs to be sufficient to enable pharmacists to, or to
incentivize pharmacists to, work this into their daily
operation.” Overall 69% would participate in a pilot project
to implement independent pharmacist prescription of
hormonal contraception.
The majority of respondents indicated that task-sharing of
hormonal contraception prescription by pharmacists would
be an important service to provide: “…where I work…there
is no female doctor in town. So having the option of a female
pharmacist would probably be good for a lot of patients.”
All respondents indicated a reasonable knowledge of the
contraindications, compliance considerations, and the rec-
ognition and management of routine and rare side effects
regarding each of the range of prescription contraceptives,
with the most confidence in their knowledge of oral
contraceptives, somewhat less with respect to transdermal
patches and vaginal rings. During interviews, the most
common theme was a desire for specific training: “I wouldcertainly need a spruce up in terms of info. I feel that I’m
rather savvy with [my hormonal contraception knowledge],
but when I’m taking the responsibility to prescribe, I would
want more recent training.”
Pharmacists were very interested to prescribe hormonal
contraceptives, with over 80% agreeing with the statement “If
given the legislative authority today, I would be interested in
prescribing hormonal contraceptives in my pharmacy prac-
tice.” (Appendix D: Detailed Results 2). Support for this
innovation was evident among both urban and rural areas and
represented a broad geographic distribution in every health
region throughout the province: “I think it’s really a good
idea. I think we should be more involved…we’re way too far
under-utilized in what we could do in the heart of healthcare.
…We’re not just dispensing machines. We’re actually
functioning as what a pharmacist should function as…
certainly I would upgrade in a second if that was a direction
that the government was allowing us to go.”
3.3. Factors correlated with a willingness to prescribe
hormonal contraception
Logistic regression associated several factors with a
willingness to independently prescribe hormonal contracep-
tion (Table 2). After model simplification, the odds ratios
suggest that feeling comfortable to ask questions assessing a
sexual history increases the odds of being willing to
independently prescribe contraception by about 13 times;
being an Innovation-adopter increases the odds by about 10
times; for every decrease of 1-year experience in practice, the
odds of being willing to prescribe increases by about 9%;
feeling that lack of staff is not an important barrier to the
innovation increases the odds by about 7 times and feeling
that resistance from the public is not an important barrier
increases the odds by about 6 times.
Similarly for regressions assessing factors correlated with
the willingness among community pharmacists to be
involved in a pilot project, we found a number of correlates
(Table 3). We ascertained that being an Innovation-adopter
increases the odds of being willing to participate in a pilot
program by about 8 times, feeling comfortable using a
protocol to assess the degree of risk due to sexual history
factors increases the odds by about 6 times and feeling that
liability concerns were not an important barrier to imple-
mentation increases the odds of being willing to participate
Table 3
Logistic regression results for pharmacists willing to participate in pilot to independently prescribe contraception
Associated Factor Willingness to prescribe, OR (95% CI) Significance
Self-defined Innovation adopter 8.33 (3.23–25.0) pb.001
Comfort taking a sexual history assessment using a protocola 6.4 (2.5–17.9) pb.001
No liability concerns 3.33 (1.28–9.09) pb.05
Shown are odds ratios (95% CI) and p values from the likelihood ratio tests.
a Likert scale from 1 to 5.
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typified in interviews by comments such as this: “And the
bottom line is, if you wanted to try something tomorrow, just
let us know and we’ll be ready to roll.”4. Discussion
Our mixed-methods study has demonstrated that inde-
pendent prescribing of hormonal contraception is highly
acceptable and feasible to implement at a selection of
community pharmacies widely distributed throughout BC.
Responses were received by 39% of pharmacies, yet every
region and subregion in the province were represented,
indicating that expanding the scope of practice for
pharmacists in this way has potential to increase access to
prescription contraception for women in all areas.
Our findings among Canadian pharmacists support those
found among similar models for pharmacist task-sharing in
contraception provision in the United States [9,10,31]. Similarly,
BC implemented a registered nurse contraception task-sharing
model in 2009 [11]. However, contraception management
certified nurses have indicated that limited availability of
contraceptive stock at their place of employment, and of hours
for provision of this service, can curtail their ability to provide
appropriate access to contraceptives [32,33]. Conversely,
independent pharmacist provision offers availability of a full
range of contraceptive options and of extended service hours.
The model implemented by Guilbert et al. in Quebec [34]
overcomes some of these concerns and has demonstrated the
willingness of pharmacists to work with certified nurses to
implement a system of nonphysician access to hormonal
contraception [35–37]. Once the certified nurse has utilized
decision-making tools to determine an appropriate contraceptive
for a woman, she then presents a written “direction” from the
nurse to a collaborating pharmacist who will dispense any
among the full range of contraceptives. In contrast, we propose a
model where a contraception-certified pharmacist could directly
utilize the decision-making tools to provide an appropriate
contraceptive in a single visit. Our study has shown that selected
pharmacists find this one-stop process of access to contraception
directly at the pharmacy to be feasible and acceptable at both
urban and rural sites and in all health regions of BC.
Our response rate of 39% was lower than the 85% we had
achieved in our previous survey among physicians in BC [38]
but still improved over that achieved in the most recentcomparable pharmacist study byMarra et al. [39]. Moreover, in
this study, we aimed to understand if the proposed innovation
could be available particularly in small towns and rural areas
where there are fewer options and shorter hours at the only
current facilities for access to hormonal contraception. Our
survey respondents represent all regions of the province and are
overrepresentative of the smallest pharmacies such as those
present in areas where the fewest contraception service options
are present. Soon et al. have demonstrated stigma associated
with accessing sexual health services in such rural settings inBC
[40]. Pharmacies in small towns have the potential to offer
longer, more convenient hours including evenings and
weekends, and to offer less potential for stigmatization for
young and vulnerable women, than has been shown to be the
case for currently available options in rural settings.
Similarly, as most respondents represented pharmacies
with two or fewer pharmacists, we are encouraged that this
new innovation has potential not only to diffuse within large
organizations where organizational policy may promote
adherence but also to be seen as acceptable and feasible by
those within smaller and independent organizations.
Future studies should examine acceptability of the model
for contraception provision directly from pharmacists, among
women and girls. These concepts have been demonstrated as
acceptablewith respect to similar noncontraceptive services by
pharmacists [41,42]. Additional research should be undertaken
to demonstrate effectiveness through pilot implementation.5. Conclusion
A selection of over a third of pharmacies, representing all
areas of BC and all community pharmacy business models,
indicates that task-sharing to independently prescribe hor-
monal contraception is both highly acceptable and feasible. As
pharmacists are often the most accessible health professional,
pharmacist provision of hormonal contraceptives carries the
potential to improve timely access to contraception.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.contraception.2015.03.013.References
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